US Patent 9856264 Isoquinolinesulfonyl derivative as RHO kinase inhibitor
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
The present invention discloses a class of isoquinolinesulfonyl derivatives as RHO kinase inhibitors, and pharmaceutical compositions thereof, and relates to pharmaceutically acceptable uses thereof. Specifically, the present invention relates to a compound as represented by formula (I), or a pharmaceutically acceptable salt thereof.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Lingyun Wu0
Shuhui Chen0
Yuanshan Yao0
Zhaoguo Chen0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09856264 Isoquinolinesulfonyl derivative as RHO kinase inhibitor US Patent 9856264 Isoquinolinesulfonyl derivative as RHO kinase inhibitor
Infobox
Patent Number
098562640
Patent Number
98562640
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
098562640
Date of Patent
January 2, 2018
0Patent Application Number
153069650
Date Filed
April 21, 2015
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09856264 Isoquinolinesulfonyl derivative as RHO kinase inhibitor
Infobox
Is a
Patent jurisdiction
Patent number
09856264
Date of patent
January 2, 2018
Patent application number
15306965
Date Filed
April 21, 2015
Patent primary examiner
Find more entities like US Patent 9856264 Isoquinolinesulfonyl derivative as RHO kinase inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
